Science Explorer Interactive view Map
Company · Vienna · Austria

Intercell (Austria)

Research works
60
▼ 95% vs 2013–17
Citations
2.6k
43.9 per fractional work
Top-10% rate
0.0%
record average 16.5%
Open access
39%
world 28%

Not ranked overall: Intercell (Austria) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Intercell (Austria)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pathogenesis, Innate Immunity, Antigen Presentation, Immune Response, Vaccine Development, Vaccine and Immunity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology18▲ 7.3×30 topics
  2. Pathogenesis6▲ 18×9 topics
  3. Innate Immunity6▲ 27×4 topics
  4. Antigen Presentation5▲ 88×2 topics
  5. Immune Response5▲ 13×11 topics
  6. Vaccine Development4▲ 25×6 topics
  7. Immunity4▲ 21×3 topics
  8. Public Health4▲ 5.2×5 topics
  9. Vaccine4▲ 17×9 topics
  10. Cancer Immunotherapy4▲ 42×2 topics
  11. Dendritic Cells4▲ 50×2 topics
  12. Tumor Antigen3▲ 68×1 topic
  13. Vaccine Adjuvants3▲ 68×1 topic
  14. Antiviral Therapy3▲ 34×3 topics
  15. Genetic Diversity3▲ 9.4×3 topics
  16. Vector Control3▲ 37×2 topics
  17. Arboviral Diseases2▲ 67×1 topic
  18. Zika Virus2▲ 67×1 topic
  19. Antimicrobial Resistance2▲ 16×4 topics
  20. Liver Disease2▲ 28×2 topics
  21. Ribosome2▲ 40×1 topic
  22. Translation2▲ 19×1 topic
  23. Cancer Therapy2▲ 5.9×4 topics
  24. Genomics2▲ 11×2 topics
  25. Toll-like Receptors2▲ 22×2 topics
  26. Viral Hemorrhagic Fevers2▲ 80×1 topic
  27. Virus2▲ 31×2 topics
  28. Zoonotic Infections2▲ 62×1 topic
  29. Ecology2▲ 17×2 topics
  30. Glycosylation2▲ 16×3 topics
  31. Monoclonal Antibodies2▲ 25×2 topics
  32. Pattern Recognition Receptors2▲ 24×2 topics
  33. Therapeutic Antibodies2▲ 28×2 topics
  34. Epitope Prediction2▲ 173×1 topic
  35. Peptide-MHC Binding2▲ 173×1 topic
  36. Antibody Engineering2▲ 31×1 topic
  37. Cytokine-Mediated Link2▲ 46×1 topic
  38. Fc Receptors2▲ 31×1 topic
  39. Innate Antiviral Responses2▲ 46×1 topic
  40. Virulence Factors2▲ 17×3 topics

Which research topics does Intercell (Austria) publish most on?

By volume in 2022–2025: Angiogenesis and VEGF in Cancer, Neutrophil, Myeloperoxidase and Oxidative Mechanisms and Cell Adhesion Molecules Research.

  1. 1 Angiogenesis and VEGF in Cancer Molecular Biology 0 works
  2. 2 Neutrophil, Myeloperoxidase and Oxidative Mechanisms Immunology 0 works
  3. 3 Cell Adhesion Molecules Research Immunology and Allergy 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.0%not open61.0%

World: 28% of research is openly available.

with international co-authors48.1%domestic only51.9%

World: 19% is written across borders.

How has Intercell (Austria)'s research output changed?

Output in 2018–2022 was 95% lower than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Vienna

All research institutions in Vienna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.